A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.
Nature. 2020 Aug;584(7819):120-124. doi: 10.1038/s41586-020-2381-y. Epub 2020 May 26.
Nature. 2020.
PMID: 32454512